5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.70%
Negative revenue growth while HUH1V.HE stands at 1.83%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-52.50%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-10.23%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-10.23%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
7.12%
Net income growth comparable to HUH1V.HE's 6.58%. Walter Schloss might see both following similar market or cost trajectories.
9.09%
EPS growth 1.25-1.5x HUH1V.HE's 6.82%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
9.09%
Diluted EPS growth 1.25-1.5x HUH1V.HE's 6.82%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.19%
OCF growth at 75-90% of HUH1V.HE's 67.69%. Bill Ackman would demand better working capital management or cost discipline.
31.61%
FCF growth under 50% of HUH1V.HE's 134.97%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-33.99%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 11.79%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-23.64%
Negative 5Y CAGR while HUH1V.HE stands at 25.75%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-12.31%
Negative 3Y CAGR while HUH1V.HE stands at 72.21%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
129.37%
10Y OCF/share CAGR above 1.5x HUH1V.HE's 75.43%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
390.08%
5Y OCF/share CAGR above 1.5x HUH1V.HE's 25.34%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
38.56%
3Y OCF/share CAGR above 1.5x HUH1V.HE's 4.56%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
154.88%
Below 50% of HUH1V.HE's 46640.17%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-9.36%
Negative 5Y net income/share CAGR while HUH1V.HE is 81.10%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
569.68%
3Y net income/share CAGR above 1.5x HUH1V.HE's 16.22%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
12.96%
Below 50% of HUH1V.HE's 54.90%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
16.73%
5Y equity/share CAGR at 50-75% of HUH1V.HE's 30.82%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
34.63%
3Y equity/share CAGR similar to HUH1V.HE's 33.70%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.03%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.73%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
0.92%
Asset growth 1.25-1.5x HUH1V.HE's 0.65%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
4.74%
1.25-1.5x HUH1V.HE's 4.30%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-11.57%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
9.77%
SG&A growth well above HUH1V.HE's 9.48%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.